Method of treating brain cancer
US8258145B2 · kind B2 · utility
7Cited by
124References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2007 |
| Grant date | Sep 4, 2012 |
| Priority date | — |
| Expiry date | Jul 3, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to the use of these compounds in treating brain cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.